Genzyme and Isis Begin Second Phase 3 Trial Of ... (icals' Contacts: Kristina Lemonidis (...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen

Date:8/6/2008

icals' Contacts:

Kristina Lemonidis (Investors) Amy Blackley, Ph.D. (Media)

760-603-2490 760-603-2772

SOURCE Genzyme Corp.; Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Genzyme and Isis Complete Licensing of Mipomersen
2. Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
3. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
4. Genzyme Announces Presentation of New Positive Data on Carticel(R)
5. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
6. Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML
7. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
8. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
9. Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
10. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
11. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases

Post Your Comments:

Breaking Medicine Technology:Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 2 Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 3 Giant Eagle(R) Pharmacy Receives Award for Operational Excellence 2 Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2 Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3 Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4 Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5 Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6 New Oxygen Biotherapeutics Inc Investor Presentation Available on Company Website 14284 1 Leading Medical Device Provider Chooses TrackWise 28R 29 Software to Optimize Customer Complaint Handling 5074 1 Leading Medical Device Provider Chooses TrackWise 28R 29 Software to Optimize Customer Complaint Handling 5074 2 Leading Medical Device Provider Chooses TrackWise 28R 29 Software to Optimize Customer Complaint Handling 5074 3 LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results 5069 1 LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results 5069 2 LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results 5069 3 LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results 5069 4 LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results 5069 5 LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results 5069 6 LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results 5069 7 LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results 5069 8 LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results 5069 9 LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results 5069 10 LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results 5069 11 LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results 5069 12

[0] Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan [0] Giant Eagle(R) Pharmacy Receives Award for Operational Excellence [0] Reportlinker Adds Medical Fiber Optics - A World Market Analysis

Other Medicine Technology:Cequent Pharmaceuticals' Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008 2 Cequent Pharmaceuticals' Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008 3 AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 2 AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 3 AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 4 AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 5

Cequent Pharmaceuticals' Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008 AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication

Breaking Medicine News(10 mins):Health News:Bishops Deeply Disappointed by Senate Vote to Table Nelson-Hatch-Casey Amendment 2 Health News:Polar Pump: E85 Fuel Now Available in Warroad, Minn., Northernmost Outlet for the Fuel in USA 2 Health News:Seasonal Flu Vaccination Rates Still Too Low 2 Health News:Seasonal Flu Vaccination Rates Still Too Low 3 Health News:Dr. Daniel Von Hoff named honoree of Scottsdale Healthcare Foundation Honor Ball 2 Health News:Dr. Daniel Von Hoff named honoree of Scottsdale Healthcare Foundation Honor Ball 3

[1] Bishops Deeply Disappointed by Senate Vote to Table Nelson-Hatch-Casey Amendment [0] Polar Pump: E85 Fuel Now Available in Warroad, Minn., Northernmost Outlet for the Fuel in USA [0] News brief: Dermatologic infections in cancer patients treated with EGFRI therapy [0] Seasonal Flu Vaccination Rates Still Too Low [1] Dr. Daniel Von Hoff named honoree of Scottsdale Healthcare Foundation Honor Ball

Other Medicine News:Health News:Halloween Events in Redding, Calif., Bring Young and Old Together for a Ghoulish Good Time 2 Health News:Halloween Events Bring Young and Old Together for a Ghoulish Good Time 2 Health News:SNM ad urges congress to fund nuclear medicine research 2 Health News:New Drug Promising Against Tough-to-Treat Kidney Cancer 2 Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 2 Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 3 Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 4 Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 5 Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 6 Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 7 Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 8 Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 9 Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 10 Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 2 Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 3

Halloween Events in Redding, Calif., Bring Young and Old Together for a Ghoulish Good Time Halloween Events Bring Young and Old Together for a Ghoulish Good Time SNM ad urges congress to fund nuclear medicine research New Drug Promising Against Tough-to-Treat Kidney Cancer STERIS Corporation Announces Fiscal 2008 Second Quarter Results HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053

Medicine Products:

Anti-Smith (ENA) Antibody Anti-Scleroderma (Scl-70) (ENA) Antibody Anti-RNP (ENA) Antibody Anti-Phospholipid Syndrome